The next 20 years of human genomics must be more equitable and more open
By Nature Staff,
Nature
| 02. 10. 2021
The first drafts of the human genome, published in Nature and Science 20 years ago, flung open the doors for what some predicted would be ‘biology’s century’. In just one-fifth of the century, the corpus of information has grown from two gappy and error-filled genome sequences to a full account of the genetic variation of hundreds of thousands of individuals around the world, and an increasing number of tools to study it. This special issue of Nature examines how far the human genome sequence has taken us, and how far we have to go. But some aspects of the research ecosystem around the human genome have hardly changed, and that remains a concern.
Many of the ethical, legal and social implications of genome research — including questions of privacy, informed consent and equitable representation of researchers and participants — remain unresolved. Moreover, free and open access to genome data remains unevenly implemented. Just this week, researchers pointed out the problems caused by lack of accessibility to coronavirus genomes in the middle of a pandemic. Researchers, funders and journals will...
Related Articles
By Carl Zimmer, The New York Times | 06.04.2026
Scientists at Columbia University have edited the DNA of early human embryos with unprecedented accuracy, an achievement that could open the way to babies engineered with particular characteristics.
The prospect has fueled controversy for years. On the one hand, the...
Faster, Higher, Stronger was the Olympic motto from 1874 until 2001, when “ – Together” was added, to stress the “moral and educational perspective” of the Games. The folks who paid for or participated in the Enhanced Games – the name itself a nod to the Olympics – held in Las Vegas on Sunday, May 24, apparently use a different edit:
Faster, Higher, Stronger with Chemistry
High-level sport draws huge crowds. Coming very soon, the soccer World Cup, featuring...
By Gina Kolata, The New York Times | 05.25.2026
In a small, preliminary study, an experimental gene-editing treatment dramatically lowered cholesterol levels, perhaps permanently, after just one infusion, scientists reported on Monday.
If confirmed in larger studies, researchers hope the findings may lead to a one-and-done way to prevent...
By Ryan Cross, Endpoint News | 05.20.2026
BOSTON — Over the past year, I’ve begun hearing rumblings from scientists who secretly think it’s time to stop being stodgy about editing the genes of human embryos.
For the most part, they are still too timid to speak up...